In particular, the epidermal growth factor receptor (EGFR) is known to be overexpressed in a variety of human cancer cell lines including pancreatic, breast, and colorectal cancers, and thus is an ideal marker for targeted tumor therapy [4,5]. The gene discussed is EGFR; the disease is neoplasm.